FDA Grants 510(k) Clearance To Viz.ai’s Viz Subdural Plus Module - Data Intelligence
Summary by Plato. Vertical Search. Ai. | PlatoAiStream. Data Intelligence. Vertical Search. Ai.
2 Articles
2 Articles
All
Left
Center
Right
FDA Grants 510(k) Clearance To Viz.ai’s Viz Subdural Plus Module - Data Intelligence
Viz.ai leverages AI algorithms and machine learning to expedite diagnosis and care. Credit: T Schneider / Shutterstock. The US Food and Drug Administration (FDA) has granted 510(k) clearance to Viz.ai for its Viz Subdural Plus module, designed for enhancing clinical decision-making. It is claimed to be the first solution to quantify the size of collections such as subdural haemorrhages (SDH) in the subdural space on non-contrast computed tomogra…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium